MMJ Investors Forum

[JohnCM]

Police raid eight Sweet Leaf Marijuana Center locations in Denver and Aurora

All 11 Denver-area Sweet Leaf stores are closed and its 26 licenses have been suspended.

PUBLISHED: DEC 14, 2017, 12:25 PM • UPDATED: 14 DAYS AGO COMMENTS (80)
By Alicia Wallace, The Cannabist Staff

Denver police on Thursday raided eight Sweet Leaf Marijuana Center locations in Denver and Aurora and arrested 12 people as part of a yearlong investigation into illegal marijuana sales.

The criminal activities alleged included sales of cannabis in violation of the 1-ounce-per-person limits established under Colorado marijuana law, Denver police officials said in a statement.

The Denver Department of Excise and Licenses in concert with the police action suspended 26 licenses for medical, retail, cultivation and extraction operations that conduct business as Sweet Leaf, said Dan Rowland, spokesman for the excise and licenses department.

The suspension order stated: “Reasonable grounds and probable cause exists to believe that respondents have engaged in deliberate and willful violations of state and local laws or regulations, and/or that the public health, safety and welfare requires emergency action.”

Names of the 12 people arrested were not immediately released. They were being booked into the Downtown Detention Center.

Police said the operation was conducted after a criminal investigation into the illegal distribution of marijuana at eight locations. The alleged criminal violations are related to the sale of marijuana in excess of allowable amounts established by Amendment 64, which allows for the personal use of marijuana, according to a police department news release.

No other marijuana businesses were included in the raids, police said.

Sweet Leaf representatives said in an emailed statement that they were surprised by the police raids.

“It is unclear at this point exactly what actions, if any, Sweet Leaf took to cause the city to issue this order,” the statement said. “Sweet Leaf is cooperating with the authorities to resolve this issue and hopes to have all of their stores back in operation as soon as possible.”

It was not immediately clear to what extent Sweet Leaf’s facilities were affected beyond Denver and Aurora.

Although the Aurora store was raided, and no one answered the location’s phone on Thursday, the city has not suspended Sweet Leaf’s business license for its East Sixth Avenue store, said Julie Patterson, an Aurora spokeswoman.

“We are waiting to receive more information from police investigators to determine whether we need to take any action,” she said.

Sweet Leaf’s dispensary in Portland, Ore., remained opened, a person who answered the store’s phone said. The employee said store officials declined to comment.

The coordinated enforcement action was solely a Colorado agency effort headed by Denver police, which partnered with the Aurora Police Department, Colorado Marijuana Enforcement Division, Denver District Attorney’s Office, Denver City Attorney’s Office, Denver Department of Excise and Licenses and Denver Department of Public Health and Environment.

The U.S. Drug Enforcement Administration was not involved in the operation

[JohnCM]

1. PHIVIDA OTCPINK:PHVAF
2. ISODIAL OTCQB:ISOLF
3. DOJA OTCPINK:DJACF
4. CANNABIS WHEATON OTCQB:CBWTF
5. CRONOS GROUP OTCPINK:PRMCF
6. EMBLEM OTCPINK:EMMBF
7. NAMASTE OTCQB:NXTTF
8. EMERALD HEALTH OTCQX:EMHTF
9. MPX OTCQB:MPXEF
10. ETF NYSE:MJX

[bears3434]

The MJ GURU “ SLLEKSCAPE” A MUST Read Thesis for
The 2018 CALIF. BOOM!!

His picks included!!

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=137171428

The Twin Peaks $$$

[JohnCM]

ETF Managers Group Announces MJX Live for Trading on the NYS
December 26, 2017

SUMMIT, N.J.--(BUSINESS WIRE)
ETF Managers Group LLC (“ETFMG”) announced today that MJX, the ETFMG Alternative Harvest ETF is live and available for trading on the NYSE Arca. This fund is one of the first of its kind available to U.S. investors allowing them access to a unique sector in this rapidly evolving market. MJX is designed to replicate the Prime Alternative Harvest Index, which tracks companies likely to benefit from the increasing global acceptance of various uses of the cannabis plant.

This includes treatments from innovative medicinal breakthroughs involving the plant’s unique properties – the result of years of significant research by the global biotech and pharmaceutical community.
Sam Masucci, Founder & CEO of ETF Managers Group said: “As an ETF issuer we are excited about opportunities for innovation, the chance to give investors exposure to new markets and doing our part to impact the continued evolution of the ETF industry by meeting the appetite of investor interest.”

The ETFMG Alternative Harvest ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Prime Alternative Harvest Index. For more information on the Fund please visit: www.MJXetf.com.

Effective December 26th, 2017, the Fund’s name (previously the Tierra XP Latin America Real Estate ETF, ticker symbol: LARE) has changed to the ETFMG Alternative Harvest ETF, ticker symbol: MJX. The Fund’s underlying index has been changed to the Prime Alternative Harvest Index which is provided by Prime Indexes and will be calculated by Solactive AG. Information about the index can be found by visiting www.primeindexes.com.

There’s a new cannabis ETF on the block. ETFMG, Alternative Agroscience ETF, is the first U.S. traded fund dedicated to investing in marijuana cultivators and distributors.In truth, it’s not exactly new, but a complete rebuild of an existing fund.

Actually, ETF Managers Group (ETFMG) is remaking its existing Tierra XP Latin America Real Estate ETF (NYSEARCA:LARE) with an updated strategy.

ETF Managers Group | ETF Investments | ETF Stocks | Exchange ...

http://www.etfmgfunds.com/

ETFMG provides accelerated entry to market for all ETF types, targeted wholesaling and marketing.

Hot off the New York Stock Exchange, the Alternative Agroscience ETF will begin trading on Dec. 26, 2017.

Actually, ETF Managers Group (ETFMG) is remaking its existing Tierra XP Latin America Real Estate ETF (NYSEARCA:LARE) with an updated strategy. Changing from an international real estate investment trust (REIT) fund, the new ETF will track cannabis cultivators, producers and distributors, along with cannabinoid drug makers, fertilizer producers and tobacco companies.

As the first U.S. marijuana ETF, the Alternative Agroscience could enjoy a first-mover advantage and capture the important growing cannabis investing market share.

A New Marijuana ETF Is Coming to the New York Stock Exchange

Nov 19, 2017 - For the first time ever, an exchange traded fund (ETF) with exposure to the marijuana industry has received approval to join the New York Stock Exchange (NYSE). The new ETF will provide investors with a simple way to access a burgeoning cannabis industry that some say is the biggest market opportunity.

NYSE Marijuana Fund

Beginning Dec. 26, investors will be able to purchase the Alternative Agroscience ETF through a NYSE subsidiary. The ETF tracks the Alternative Agroscience Index, which seeks exposure to ventures primarily engaged in the cultivation, production and distribution of cannabis products. The investment universe includes companies involved in the manufacturing of cannabinoid-related drugs, businesses that make fertilizers and pharmaceuticals.
Say Hello to the Very First Marijuana ETF You Can Buy in the U.S. ...

1.
Nov 20, 2017 - ETF Managers Group is switching the focus and tracking index of an existing ETF, the Tierra XP Latin America Real Estate ETF (NYSEMKT:LARE), which tracks the Solactive benchmark of real estate in Mexico and Brazil, to an ETF that predominantly follows cannabis companies. Why make the switch?

Say hello to the very first marijuana ETF for the U.S.
As reported by CNBC, on Oct. 27, ETF Managers Group filed for a new ETF, the Alternative Agroscience ETF. This ETF will mimic an index as closely as possible that tracks cannabis cultivators, producers and distributors, cannabinoid drugmakers, fertilizer producers, and tobacco companies.

According to a Securities and Exchange Commission filing, the switch to a cannabis-based index will occur on Dec. 26, so there's still a few weeks to go before investors will have an ETF that truly tracks marijuana stocks.

It’s risky to call American Growth Funds Series Two Class E (MUTF:AMREX) a conservative marijuana pick. The fund, comprised of companies involved in the legal cannabis industry has a 5.75% load and dismal returns, with a 5-year annualized loss of -2.48% and year to date decline of 22%.
Yet, if you’re a contrarian seeking a fund with access to the cannabis industry you might consider beaten down AMREX. For optimistic investors, the stock is trending upward during the first few weeks of December.
AMREX’s top holdings include some well-known names and other niche pot players including GW Pharmaceuticals PLC-ADR (NASDAQ:GWPH), Scotts Miracle-Gro Co (NYSE:SMG), Abbott Laboratories (NYSE:ABT), Cara Therapeutics Inc (NASDAQ:CARA), Cannabis Sativa Inc (OTCMKTS:CBDS) and more.
The fund is small and hasn’t gained serious investor traction. With a 3-year beta of 0.53, this might be a good diversifier against the movements of the S&P 500.

[JohnCM]

WEED ETF US 12/26/2017

[JohnCM]

You'll also notice that there are no publicly-traded US marijuana producers listed on any US exchanges, again because US stock market is subject to federal regulations so it would be the same as if a cocaine producer wanted to go public here.

[JohnCM]

The Canadian tickers really ramped up and just now I am looking to reinvest in MJ? Oh well. Looking at legit companies only. VIDA/MDCL/DJACF

[ZipCash]

Very , very bullish 2018 is upon us

MJ STRONG HERE WITH CHIT $$$$

[JohnCM]

Roughly two weeks ahead of the Jan. 1 launch of California’s legal cannabis market, state regulators have granted the first batch of temporary cannabis business licenses.

On Thursday, the Bureau of Cannabis Control issued 20 licenses for medical and adult-use operations, including retailers, distributors, microbusinesses, and a testing laboratory. Though the licenses have now been granted, they won’t be valid until Jan. 1.

The companies that received licenses stretch from San Diego to Shasta County and include:

Pure CA (Lynwood) — distributor, medical and adult-use

Buddy’s Cannabis (San Jose) — microbusiness, medical and adult-use

HERBL Distribution Solutions (Santa Rosa) — distributor, medical

Golden State Sciences (King City) — distributor, medical

Yes (Monrovia) — laboratory testing

Torrey Holistics (San Diego) — retailer, medical and adult-use

KindPeoples (Santa Cruz) — retailer, medical and adult-use (x2, for two separate locations); distributor, medical and adult-use; microbusiness, medical and adult-use

Hueneme Patient Consumer Co-op (Port Hueneme) — retailer, medical

530 Cannabis (Shasta Lake) — retailer, medical and adult-use

To date, more than 200 applications have been submitted through the Bureau of Cannabis Control’s online system, according to a bureau press release, with many more expected to roll in during the coming months. So far more than 1,900 users have registered with the system, the bureau said.

Products manufacturers, meanwhile, are licensed by the state Department of Public Health’s, which began accepting applications through its website last week. The a department spokesperson told Leafly via email that so far eight temporary licenses have been issued.

[JohnCM]

Thank you for your patience. I am finally out with my 2018 MJ stock picks.

PHIVIDA CNSX:VIDA
MEDICINE MAN OTCQB:MDCL
DOJA OTCPINK:DJACF
GOLDEN LEAF OTCQB:GLDFF

[JohnCM]

I am surprised. I hate SIPC.

2018 GRAND SALAMI STOCK PICKS


The concluding section of THE 2018 MARIJUANA MANIA THESIS described a specific methodological key to picking the very best performing stocks by % gain inside of a marijuana sector mania.

---

THE SUBSECTOR SUPERMANIA

The key to the biggest returns during a MJ MANIA

When reviewing the stocks ranked by % gain from highest to lowest in THE 2014 MJ MANIA, it became apparent that stocks in the same subsector did not trade independently of one another, but instead tended to trade in specific clustering patterns stratified by performance. The mania was so strong in 2014 that nearly every marijuana stock achieved tremendous gains; however, it was readily apparent that certain subsectors vastly outperformed others. Vaporizer stocks generally experienced superior returns, in comparison to other subsectors such as lighting, security and financing. Stocks whose primary business plan revolved around vaporizers, along with stocks who merely announced they were entering the vaporizer industry became absolute rockstar Kangaroos hopped up on Adderall. Everybody who witnessed the unfolding of the mania remembers the singular posterchild encapsulating the utter ridiculousness of it all as the vaporizer play SPLI meteorically rose 75000% in 10 weeks.

The utter dominance of the vaporizer subsector during the 2014 MJ Mania calls out for a new term: SUPERMANIA.

Although stocks residing in the Supermania subsector generally possess the greatest potential to experience the rarefied air of 99th percentile returns, the clustering of stocks within a given subsector by performance was not so clean and absolute that every single vaporizer stock achieved the most superior returns. Many of them did not.

Only the very best of breed stocks within the vaporizer Supermania vastly outperformed nearly every other stock in the MJ universe to achieve Superman-like returns.

We saw a similar phenomenon during the 2016 MJ Mania where the best performing subsector this time around was the all-purpose cannabis stocks. There were more than a dozen of them and as a subsector they handily outperformed the MJ sector as a whole.
But only the top stocks in that subsector – MCOA, AMMJ, and CNAB -- participated in the SUPERMANIA.

In early 2017, a SUPERMANIA in cannabinoid pharmaceutical stocks occurred, and once again only the very best of breed stocks in that subsector participated in it -- OWCP and CNBX.

So it seems the key to picking the very best stocks in the 2018 MJ MANIA will be to first predict which subsector will experience the SUPERMANIA, followed by identifying the best of breed stocks in that subsector.
---

The final sentence describes the very essence of the task at hand.

“So it seems the key to picking the very best stocks in the 2018 MJ MANIA will be to first predict which subsector will experience the SUPERMANIA, followed by identifying the best of breed stocks in that subsector."

After spending an inordinate amount of time reading articles and reports, attending exhibits and conferences, speaking with industry connections, participating in all kinds of discussion forums, studying data from a wide variety of websites and social media, and many hours of just plain old thinking, I arrived at the most probable subsector to experience a Supermania during THE 2018 MARIJUANA MANIA.


PROJECTED 2018 SUPERMANIA:

CANNABINOID-INFUSED BEVERAGES
(HEMP AND CBD BEVERAGES)

Now that we’ve pinpointed the Supermania, the next step is to identify the best of breed stocks in that subsector.

The top two tickers in this group possess the highest SALAMI scores by a wide margin and are clearly the best stocks in the Cannabinoid-Infused Beverage subsector.

Despite such a decisive margin, a number of questions ran through my mind.

What if the Hemp and CBD Beverage subsector does not experience a Supermania next year?

What if there is no specific Supermania in 2018?

Shouldn’t I also do a SALAMI analysis on the marijuana sector without taking into account the projected SUPERMANIA to see how these two stocks stack up against the rest of the field?

Or should I stick with my conclusion and maintain the adjustments made in the sentiment-based SALAMI factor scores and IPA subscale scores -- like I did with THE 2016 GRAND SALAMI selections of MCOA, AMMJ and CNAB -- to account for the projected SUPERMANIA?

Being someone who attempts to eliminate as many uncertainties as possible, it was an easy decision for me to run both analyses.

The results were very telling.

In each analysis, the same two stocks achieved the highest final SALAMI scores.

The verdict was crystal clear.

VATE and SIPC would enter THE 2018 GRAND SALAMI.

[JohnCM]

This is what I am looking for ...

*Company to capitalize on rec CA legalization
*Preferably Organic
*Priced at 25 cents or higher
*Capitalized
*Preferably into MMJ
*Preferably looking to have dispensary location with great marketing brand

[Cheetah SPEED]

Prefer Canadian MJ stocks as investments but if you’re going American I’ve heard good things about $GBLX

[JohnCM]

Looking for the number one legalized California recreation marijuana play for 2018.

Not a speculative, favorite stock to take a flyer on.

I am taking about a solid, bona fide, company with an existing network, business, and/or locations.

[yerboss]

$NINE:TSX-V, Delta 9 Cannabis, in the news and on the march. Up over 30% in first 90 minutes of trading on "joint" news with $WEED:TSX, Canapy Growth. Up from $1.50 2 days ago, now $3.75 and continuing to climb!NINE

[yerboss]

The TSX is the best place to be listed from a strict regulatory and credibility POV. However, I could see a joint listing once they meet NASDAQ and/or NYSE requirements.

They already meet the price and shareholder requirements....

[JohnCM]

Let me know when there is a foreign issue ticker.

[yerboss]

$NINE:TSX-V opens to trade Monday Nov, 6th. Manitoba Licensed Producer, backed by Cannaccord Genuity, will be a great opportunity for those who get in early.

[JohnCM]

Thoughts?

[BERKSHIRE AGENT]

APRU .0016 Massive Find~~~~> HEMP MEDS is huge CUSTOMER for APRU!!!!

QUOTE
$APRU SUPPLIES TO HEMP MEDS$$!!



$APRU

[Clonefan]

Check out ViaDerma VDRM - Explosive news and Diabetic Conference this week.

$VDRM news!!

Last month we ran from .018 to .069 3 days after news! This news is much BIGGER!

March 20, 2017 08:00 ET

ViaDerma Receives Provisional Patent Numbers for Its FDA Registered Viabecline and Cannabis Technologies, and Seeks to Distribute its Products with a Management, Marketing and Distribution Company in Canada to Approved International Cannabis Countries
The Company will Target Countries where Medical and Recreational Cannabis Sales are Legal and Accepted and Scientific Research is Allowed

LOS ANGELES, CA--(Marketwired - March 20, 2017) - ViaDerma, Inc. (OTC PINK: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, recently announced today that the President, Dr. Christopher Otiko has received the Provisional Patent number for two patents pending. The Cannabis Provisional Patent #62466209, a patent for delivering medical marijuana /cannabis to the body by applying the medication onto the skin in an ointment base topical solution. The second provisional patent #62433964 for enhanced antibiotic and drug delivery for "Aqueous Topical Applications" for human and veterinarian uses. The Company plans to continue to expand its (IP) "Intellectual Property Portfolio" in 2017.

The Company has signed a LOI or letter of intent to work with a Canadian-based investment group with expertise in logistics that includes distribution for the new and anticipated products. The investment group will target sales for the new patent pending products to countries that have accepted "Medical Marijuana" and "Recreational Use" of cannabis products and technologies for delivery of CBD and THC. This group will also target countries that allow the "Clinical Studies" for medical testing such as the United Kingdom and other Asian countries.

Company CEO Dr. Christopher Otiko is attending the Diabetic Foot Global Conference (DFCon 20017), at Baylor College of Medicine in Houston, Texas and on Friday 24th of March will present a poster abstract based on seven years of research treating patients with Viabecline. "In recent studies, Viabecline has been more than 96% effective in healing diabetic foot ulcers within 4 weeks. This effect is more pronounced in more severe wounds, and the effect is the same whether the wound is infected or not," said Dr. Otiko. "Our goal is to have Viabecline added to all diabetic foot ulcer treatment protocols."

"We are also continuing the clinical testing stages of an anti-aging topical solution, a topical pain medication, a topical for male-pattern baldness, and a topical designed to boost male libido. The market for our many products is very promising. We are enthusiastic about the results we have achieved to date in terms of the anecdotal feedback we have received from the medical community," said Dr. Otiko.

About ViaDerma, Inc.
ViaDerma, Inc. (OTC PINK: VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. ViaDerma's lead product, Viabecline, uses an innovative transdermal delivery method that allows for application of active ingredients in a topical form. This patent-pending dual carrier transdermal technology may be applied in products within the medical and cosmetic markets. Also, a patent application using the combination of CBD and THC with the delivery system was filed in 2017. The use of CBD is aimed at the reduction of inflammation and for the treatment of several diseases, such as, nicotine addiction, fibromyalgia, Cohn's disease, schizophrenia, migraine headaches, pain management for cancer and Multiple Sclerosis. For more information, please visit: www.viadermalicensing.com

Forward Looking Statements
Forward-Looking Statements certain statements in this release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified using words such as "anticipate," "believe," "expect," "future," "may," "will," "would," "should," "plan," "projected," "intend," and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. The Company's future operating results are dependent upon many factors, including but not limited to the Company's ability to: (i) obtain sufficient capital or a strategic business arrangement to fund its expansion plans; (ii) build the management and human resources and infrastructure necessary to support the growth of its business; (iii) competitive factors and developments beyond the Company's control; and (iv) other risk factors. We assume no obligation to update the information contained in this news release.
CONTACT INFORMATION
Dr. Christopher Otiko
Chief Executive Officer
Email: [e-mail]
Investor Relations Phone number: 310-734-6111

[BERKSHIRE AGENT]

APRU- My new MARIJUANA stock pick. They are CONNECTED to LVVV. Everything is starting from ground floor so don't miss out. Remember I called GRCU .0003 ran to .049 and INCC .000s ran to .02+ cents. If both those ran hard in 2014 then APRU will go ballistic too imho.

$APRU

[BERKSHIRE AGENT]

Forgot about this MJ BOARD. Wish I had shared OWCP here from .0035 ran to $3+ ....MCOA .0020 to .20+.....tons of others!

[mightymoe]

have a Look at ADVT WILL grow to be on of the strongest mj players : fins coming EOM + conference calls and some promo per latest news http://ih.advfn.com/p.php?pid=nmona&article=74078423&symbol=ADVT

Swartz finished his comments by reiterating that he will be hosting a live investor conference call before the end of the quarter, and said that Advantis products will soon be featured on a TV show about cannabis. Swartz says he has been asked not to reveal the details of the show. "This will be huge for us," Swartz proudly concluded.

FULL DD POST: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129362616

[idig]

$EFFI LOOKING UP? #STOCKS #OTCBB

[jhnvtjll]

SKYF .0001 Sky440 to Manufacture and Distribute State of the Art Grow Containers

http://www.otcmarkets.com/stock/SKYF/news/Sky440-to-Manufacture-and-Distribute-State-of-the-Art-Grow-Containers?id=128345&b=y

http://www.otcmarkets.com/stock/SKYF/news/Sky440-Becomes-Current-With-OTC-Markets?id=126231&b=y

Company tweet May 5, 2016: "$skyf In the middle of a number of items that have required our full attention the past few days. Shareholder letter with updates on the way"

https://twitter.com/sky440inc
http://www.sky440.com/

[JohnCM]

Marijuana Company Of (MCOA)
0.0092 +0.0012 (15.00%)
Volume: 390,951 @ 12:21:52 PM ET

[startingboy]

start to load all the MJ stocks with the elections coming up and sanders or hillary win, this sector is the next gold imo!

[idig]

$EFFI UP 40% & CLIMBING ! $$$ #MJ

[Grifter]

Should check out INCC -- just a damn stupid steal right now.

[Carjockey2]

Looking forward to September and getting the OTC rockin again!!

[Grifter]

Oregon becomes the fourth state to legalize recreational marijuana.

http://news.yahoo.com/oregon-legalizes-marijuana-pot-day-one-185120175.html

[Grifter]

Frontier Indoor Garden Solutions and Urban Horticultural Supply Announce Partnership

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=114607082

[Grifter]

This board has gone to pot. No pun intended.

[DFLY]

TCKF waking nicely .61 nHOD 2 til 1.01 now!))

[DFLY]

TCKF thin MJer with news 13m OS 3m float..hoping pulls a CANN type move to multi dollars!!

[Lebowsky]

MDCN - BBC REPORT!!! It's official!!! CANADA NOW LEGAL!!! ALL FORMS!!!

http://www.bbc.com/news/world-us-canada-33098923


MDCN - Taking the sector by storm!!! Edibles in Canada!!!

MDCN

[Grifter]

INCC with The Stock Radio interview:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=114353596

[Grifter]

Well, what happened to this board?

[JohnCM]

Organigram OTCMKT OGRMF

ask 0.35

organically grown, non irradiated bud

licensed grower and seller CA



... if history is an indication

[entrepreneur61590]

Im surprised I don't see anything about Surna, Inc (SRNA) here... Although the stock has been in decline, various analysts are listing SRNA as a strong buy. Others have picked it up on their radar as indicating a technical reversal.. About SRNA... They deal with high efficiency controlled climate solutions for growing medical cannabis. They sell and install proprietary systems that efficiently manage humidity, temperature, and airflow, and I believe CO2 as well. Cannabis is a difficult plant to grow, and requires optimal conditions. They also have a proprietary light reflector that maximizes use of the high wattage light systems required to mimic UV from the sun. When MMJ is in its vegetative state of growth, the "fan leaves" prevent light from reaching the lower branches therefore lighting from above isn't optimal without the use of a reflector. Too close, the plants burn, too far away, they don't grow to their maximum potential. There are licensed growers across the U.S. currently testing these reflectors.

There is a conference call at 4:15 (EST). Get in before the hype!

http://www.otcmarkets.com/stock/SRNA/news/Surna--Inc--Announces-Shareholder-Conference-Call?id=102728&b=y

SRNA

[idig]

$QASP MMJ COULD RUN BIG THIS WEEK. $$
~HUGE REVENUES~
http://marijuanastocks.com/qasp-moving-forward-with-cultivation-and-forms-new-partnerships/
#MARIJUANA
GYOGZ.COM

[BERKSHIRE AGENT]

MARCH MADNESS= MARIJUANA SECTOR EXPLOSION ABOUT TO START $$$$$$$$$$$$$$$$$

#MARIJUANA

[Carjockey2]

Looks like March is starting to heat up in the MJ sector!!!

[BERKSHIRE AGENT]

IJJP~> KEY HIGHLIGHTS of News from today...........

Securities Counselors will file a court amendment to reflect these changes. Additionally, the amendment will include the Cannaworx project.

IJJ Corporation had originally announced its commitment of stock for the Medical Marijuana expansion program was 2,094,857,143 shares and had previously announced that the number would not exceed 1,020,867,796 shares.

Today's announcement further reduces that number to 625,029,345 IJJ shares.


The 395,838,451 free trading shares will be returned and retired to the treasury; thus reducing the outstanding shares by a like amount.

"IJJ Corporation's targeted capitalization program is designed to expand its partnership business directive.

However, we will do so in a strategic process that brings value to IJJ Corporation and our shareholders, at the least possible cost, including share issuances," states Clifford Pope, President, and CEO of IJJ Corporation.

"The reductions reflect IJJ Corporation's commitment for our fiduciary responsibilities to maximize shareholder value," concludes Mr. Pope.

[CashMoneyExpress]

IJJP Certainly The Next Big Big Cannabis Giant In The Seedling Stage Now,,,But Not For Long !!!

IJJP Gotta Be In It Too Win It !

[BERKSHIRE AGENT]

IJJP~ IJJP is set to Become The #1 Medical Cannabis Stock. Mr Pope, I Know With Your Leadership We Can Be The #1 Medical Cannabis Stock. Life Changing / Life Saving Cannabis Medicines Curing Cancer, Epilepsy, Arthritis & No More Chemotherapy In A Bag !!!

Quality Of Life & Now We Have The 'IJJP' 'Medical Cannabis CURE via our PARTNERSHIPS with the best of the best CANNAWORX + WORLD OF MARIHUANA + ALGA + AMERICAN SEED & OIL COMPANY and the list will only continue to grow exponentially!!' !!!

CANNAWORX in itself is working on developing "NEVER BEFORE SEEN MARIJUANA STRAINS"! CONNECT the dots folks.

Who is ROBERT F. CALKIN? He is a legend in the MARIJUANA industry and behind CANNAWORX our Joint Venture Partner!! HUGE $$$$$
https://www.facebook.com/robert.calkin

[CashMoneyExpress]

Fantastic Information & Here We Have "The Hottest MJ Stock"-IJJP!



Wow, Check Out This Victory For This Man With Medical Problem's!
https://search.yahoo.com/search;_ylt=AjJT3SooT5AAVWQLSY19cc2bvZx4?fr=yfp-t-304-s&toggle=1&fp=1&cop=mss&ei=UTF-8&p=cannabis%20news%20today%20michigan


IJJP Getting Hotter As We Speak!

[BERKSHIRE AGENT]

IJJP .0058~ There Is A Cure For Cancer Period !!!

Our Government Knows It, True Facts, Now Public Knowledge !!!

MedicaL Cannabis is Real, It Is Happening Now !!!

Every IJJP Shareholder Needs To Read

The US Government has known since 1974 that Cannabis cures Cancer. In '72 Richard Nixon wanted a larger budget for his war on drugs. He thought that if he proved Cannabis caused lung cancer like cigarettes do, he would get the support he needed. He gave the Medical College of Virginia 2 years to do a study on the effects of THC on the body. In '74 the study was completed. It turns out, THC when ingested in highly concentrated forms (such as eating Cannabis oil) will attack any mutated cells in your body while strengthening and rejuvenating the healthy cells. They found the PERFECT cure for Cancer. It worked fast, it worked well, it worked on many different forms of Cancer in ALL stages and it had ZERO harmful side effects. (Unlike Chemo which deteriorates your entire body and kills 1 in 5 patients. Not only that, but it dissolves ALL forms of tumors and can even combat super-bugs like MRSA.) When Richard Nixon saw the results of the study he was FURIOUS. He threw the entire report in the trash and deemed the study classified. In 1976 President Gerald Ford put an end to all public cannabis research and granted exclusive research rights to major pharmaceutical companies, who set out — unsuccessfully — to develop synthetic forms of THC that would deliver all the medical benefits without the “high.”We only found out about the study a few years ago thanks to dedicated medical and law professionals who filed Freedom of Information Requests. The Govt lied for many reasons.. One of the main reasons is Pharmaceutical Companies. They spend billions every year lobbying to keep Cannabis illegal because they make TRILLIONS off Cancer drugs and research. They are already well aware that Cannabis cures Cancer. They have a great con going at the moment. Cancer patients and their loved ones will spend their entire life savings or even sell their houses and businesses in order to pay for Chemotherapy and other Cancer treatment drugs. From "The Mind Unleashed".

[CashMoneyExpress]

$$IJJP$$ PowerBull Growing Stronger By The IJJP New's Release$$$